MedPath

Pyridoxine

Generic Name
Pyridoxine
Brand Names
Alertonic, Animi-3 With Vitamin D, Bonjesta, Citranatal B-calm Kit, Citranatal Harmony, Concept Ob, Diclectin, Diclegis, Folbic, Foltabs, Fortaplex, Infuvite, Infuvite Pediatric, Irospan 24/6 Kit, Isotamine B, Mvc-fluoride, Mvi Pediatric, Natafort, Neo-bex, Pregvit, Tandem Plus, Vitafol-one
Drug Type
Small Molecule
Chemical Formula
C8H11NO3
CAS Number
65-23-6
Unique Ingredient Identifier
KV2JZ1BI6Z
Background

Pyridoxine is the 4-methanol form of vitamin B6, an important water-soluble vitamin that is naturally present in many foods. As its classification as a vitamin implies, Vitamin B6 (and pyridoxine) are essential nutrients required for normal functioning of many biological systems within the body. While many plants and microorganisms are able to synthesize pyridoxine through endogenous biological processes, animals must obtain it through their diet.

More specifically, pyridoxine is converted to pyridoxal 5-phosphate in the body, which is an important coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, and aminolevulinic acid. It's important to note that Vitamin B6 is the collective term for a group of three related compounds, pyridoxine, pyridoxal, and pyridoxamine, and their phosphorylated derivatives, pyridoxine 5'-phosphate, pyridoxal 5'-phosphate and pyridoxamine 5'-phosphate. Although all six of these compounds should technically be referred to as vitamin B6, the term vitamin B6 is commonly used interchangeably with just one of them, pyridoxine .

Vitamin B6, principally in its biologically active coenzyme form pyridoxal 5'-phosphate, is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA) .

Pyridoxine is used medically for the treatment of vitamin B6 deficiency and for the prophylaxis of isoniazid-induced peripheral neuropathy (due to Isoniazid's mechanism of action which competitively inhibits the action of pyridoxine in the above-mentioned metabolic functions). It is also used in combination with Doxylamine (as the commercially available product Diclectin) for the treatment of nausea and vomiting in pregnancy.

Indication

Pyridoxine is indicated for the treatment of vitamin B6 deficiency and for the prophylaxis of Isoniazid-induced peripheral neuropathy. It is also approved by Health Canada for the treatment of nausea and vomiting in pregnancy in a combination product with Doxylamine (as the commercially available product Diclectin).

Associated Conditions
Back pain, Dizziness, Fever, Headache, Hepatic; Functional Disturbance, Hepatitis, Iron Deficiency Anemia (IDA), Ketosis, Macrocytic anemia, Menière's Disease, Menstrual Distress (Dysmenorrhea), Metabolic Acidosis, Motion Sickness, Myalgia, Nausea and vomiting, Neuralgia, Sciatic, Neuritis, Neurological Conditions caused by B Vitamin Deficiency, Secondary anemia, Toothache, Toxinfectious state, Trigeminal Neuralgia (TN), Vitamin B1 deficiency, Vitamin B12 Deficiency, Vitamin B6 Deficiency, Vitamin Deficiency, Minor aches and pains, Minor pain
Associated Therapies
Nutritional supplementation, Supplementation, Vitamin supplementation, Wellness of the Liver

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV

Phase 2
Terminated
Conditions
HIV Infection
Tuberculosis
Interventions
Drug: Standard-dose Lopinavir/Ritonavir
Drug: Double-dose Lopinavir/Ritonavir
First Posted Date
2012-05-18
Last Posted Date
2018-02-13
Lead Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Target Recruit Count
71
Registration Number
NCT01601626
Locations
🇵🇪

Asociacion Civil Impacta Salud y Educacion - Miraf CRS (11301), Lima, Peru

🇧🇷

Instituto de Pesquisa Clinica Evandro Chagas (12101), Rio de Janeiro, Brazil

🇭🇹

Les Centres GHESKIO CRS (30022), Port-au-Prince, Haiti

and more 6 locations

Modafinil in Cancer Related Fatigue

Phase 3
Completed
Conditions
Cancer Related Fatigue
Quality of Life
Interventions
First Posted Date
2011-09-26
Last Posted Date
2012-03-23
Lead Sponsor
Indira Gandhi Medical College, Shimla
Target Recruit Count
217
Registration Number
NCT01440621
Locations
🇮🇳

Regional Cancer Centre, Shimla, Himachal Pradesh, India

China Stroke Secondary Prevention Trial

Not Applicable
Withdrawn
Conditions
Stroke
Transient Ischemic Attack
Interventions
First Posted Date
2011-03-17
Last Posted Date
2014-08-20
Lead Sponsor
Xijing Hospital
Registration Number
NCT01317849
Locations
🇨🇳

Xijing Hosptial, Xi'an, Shanxi, China

Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate

Phase 2
Completed
Conditions
Primary Hyperoxaluria Type I
Interventions
First Posted Date
2011-01-24
Last Posted Date
2012-10-29
Lead Sponsor
University of Cologne
Target Recruit Count
12
Registration Number
NCT01281878
Locations
🇩🇪

Children´s Hospital University of Cologne, Cologne, NRW, Germany

Preoperative Misoprostol in Reducing Blood Loss in Total Abdominal Hysterectomy (TAH)

Not Applicable
Completed
Conditions
Hysterectomy
Interventions
First Posted Date
2010-09-10
Last Posted Date
2010-09-10
Lead Sponsor
The University of Hong Kong
Target Recruit Count
77
Registration Number
NCT01199159
Locations
🇭🇰

University of Hong Kong, Hong Kong, Hong Kong

Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Capecitabine Chemotherapy

Not Applicable
Terminated
Conditions
Hand and Foot Syndrome
Interventions
Drug: placebo
First Posted Date
2008-10-07
Last Posted Date
2023-06-15
Lead Sponsor
Cook County Health
Target Recruit Count
6
Registration Number
NCT00767689
Locations
🇺🇸

John H stroger Jr hospital of cook county, Chicago, Illinois, United States

B6 Treatment for Nausea and Vomiting in Pregnancy

Phase 4
Conditions
Nausea and Vomiting Complain in Early Pregnancy
Interventions
First Posted Date
2008-10-01
Last Posted Date
2008-12-31
Lead Sponsor
Showa University
Target Recruit Count
150
Registration Number
NCT00763633
Locations
🇮🇩

Dept. Obstetric Gynecology Univ. Indonesia, Jakarta, Indonesia

Study of Pyridoxine for Hand-Foot Syndrome

Phase 3
Completed
Conditions
Hand-foot Syndrome
Interventions
Drug: Placebo
First Posted Date
2007-03-12
Last Posted Date
2014-02-25
Lead Sponsor
Asan Medical Center
Target Recruit Count
389
Registration Number
NCT00446147

Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy

Phase 3
Completed
Conditions
Hyperemesis Gravidarum
Pregnancy
Interventions
First Posted Date
2006-02-17
Last Posted Date
2016-07-22
Lead Sponsor
The Hospital for Sick Children
Target Recruit Count
76
Registration Number
NCT00293644
Locations
🇨🇦

The Hospital for Sick Children, Toronto, Ontario, Canada

The Norwegian Vitamin Trial (NORVIT)

Not Applicable
Completed
Conditions
Acute Myocardial Infarction
First Posted Date
2005-12-16
Last Posted Date
2017-05-08
Lead Sponsor
University of Tromso
Target Recruit Count
3750
Registration Number
NCT00266487
Locations
🇳🇴

Institute of Community Medicine, University of Tromsø, Tromsø, Norway

© Copyright 2025. All Rights Reserved by MedPath